Trials / Unknown
UnknownNCT03588403
TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients
Comparison of Tomotherapy Versus Intensity-modulated Radiotherapy for Patients With Nasopharyngeal Carcinoma: a Prospective,Phase II Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (estimated)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
Tomotherapy is a new radiation planning and delivery technology which may allow for delivery of higher radiation doses with less damage to normal tissues. The investigators aim to compare the treatment efficacy and quality of life between tomotherapy and intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | TOMO | Tomotherapy |
| RADIATION | IMRT | Intensity modulated radiotherapy |
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2022-07-31
- Completion
- 2022-07-31
- First posted
- 2018-07-17
- Last updated
- 2018-07-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03588403. Inclusion in this directory is not an endorsement.